Gilead announces FDA acceptance of lenacapavir NDA submissions
Gilead (GILD) announced that the FDA has accepted its new drug application submissions for lenacapavir, the company’s twice-yearly injectable ...
Deutsche upgrades Gilead to Buy on ability to offset patent cliffs
Deutsche Bank upgraded Gilead (GILD) to Buy from Hold with a price target of $120, up from $80. The company’s core HIV treatment franchise ...
Gilead got D'Arcy Carden
Dave Bautista recently commented on the possibility of his return as Drax the Destroyer in Guardians of the Galaxy 4 in the future. In 2023, Marvel Studios’ Guardians of the Galaxy 3 ended with the ...
S&P 500 Ends Down as Hot US Inflation Data Hints at Fewer Rate Cuts
According to preliminary data, the S&P 500 lost 16.58 points, or 0.28%, to end at 6,051.92 points, while the Nasdaq Composite ...